|
|
|
|
| 6th European Congress on Tropical Medicine and International Health | | September 6 - 10, 2009 Verona, Italy | | 1st Mediterranean Conference on Migration and Travel Health |
|
|
|
|
|
|
|
|
|
|
|
|
|
Tuesday, 8 September 2009
|
|
|
| | Meet the Professor
Room 1 | 08.30 – 09.15
Peter Piot (United Kingdom)
New challenges for global health today
|
| | | | Clinical Session
Room 2 | 08.30 – 09.15
Manuel Corachan (Spain)
Spot Diagnosis |  | | | | Meet the Professor
Room 3 | 08.30 – 09.15
Marc L. Ostfield (United States)
Addressing Bioterrorism Internationally | | | | | Meet the Professor
Room 4 | 08.30 – 09.15
Pat Schlagenhauf (Switzerland)
Grey areas in malaria prophylaxis |
| | | | Meet the Professor
Room 5 | 08.30 – 09.15
David Molyneux (United Kingdom)
Lymphatic Filariasis-Successes, challenges and future opportunities
|
| | | | Meet the Professor
Room 6 | 08.30 – 09.15
Giorgio Tamburlini (Italy)
Effective policies for reducing mother and child mortality
| | |
|
|
|
| | T3 HIV and TB Epidemiology and Control
Auditorium | 09.30 – 11.00 | Plenary Session
| | | | | Chairs: Haileyesus Getahun (World Health Organization), Eligio Pizzigallo (Italy) |
| | | | Speakers: |
| | | | Peter Piot (United Kingdom)
Achievements and future of the global aids response
|
| | | | Mario Raviglione (World Health Organization)
Facing MDR/XDR-TB control: policies and strategies
| | | | | Felix Salaniponi (Malawi)
HIV/TB control and health systems: what kind of interaction?
|
| |
|
|
|
| | T6P2 South – North Trends in Arboviral Disease Control
Auditorium | 11.30 – 13.00 | Parallel Session | | | | | | Opening Congress SIMET – SIMVIM | | | | | Foreword by chairs: Giancarlo Majori (President SIMET), Vincenzo Nicosia (President SIMVIM) |
| | | | Keynote Speakers: | | | | | María Guadalupe Guzmán (Cuba)
Evaluating the effectiveness of dengue control in endemic countries |
| | | | Giovanni Rezza (Italy)
Risk Assessment and Preparedness for Chikungunya, Dengue and West Nile Fever in Italy and the Mediterranean | | | | | T6P2-01
Testing the vertical transmission of chikungunya virus in Aedes albopictus using the actors of the 2007 outbreak in Italy
M. Calzolari, R. Bellini, A. Medici, P. Bonilauri, V. Sambri, F. Cavrini, M. Dottori, P. Cordioli and P. Angelini
| | | | | T6P2-02
Surveillance on vector-borne diseases in Emilia Romagna Region, Italy
L. Venturi, P. Angelini, R. Baldelli, R. Bellini, M.Calzolari, B. M. Borrini, M. Dottori, G. Poglayen, G. Rugna, C. Venturelli, E. Martiniand M. Tamba | | | | | T6P2-03
Incidence of Dengue in Australian travellers to South and South East Asia
I. Ratnam, J. Black, L. Pollisard, C. Luxemburger, E. Matchett, P. Schlagenhauf and J. Torresi |
| | | | T6P2-04
Effect of spatial fumigation with Permethrin on dengue incidence in an endemic region
F. Espinoza-Gomez, M. de la Cruz-Ruiz, O. A. Newton-Sanchez, I. Delgado-Enciso and V. Melnikov |
| | | | T6P2-05
A survey of Ixodid ticks parasiting domestic Ruminants in Ghaemshahr district, Mazandaran province, Iran
N. Hosseini Vasoukolaei, Z. Telmadarraiy, F. Babamahmudi and M. A. Oshaghi
|
| |
|
|
|
| | T1P3 Global Health Initiatives and Health Systems
Room 1 | 11.30 – 13.00 | Parallel Session
| | | | | Chair: David Sanders (South Africa)
|
| | | | Keynote Speakers: | | | | | Jeremy Shiffman (United States)
Generation of political priority for global health initiatives: a framework, and reflections on the cases of maternal mortality, newborn survival and health systems strengthening | | | | | Joseph Hubert Perriëns (World Health Organization)
Optimising Global Health Initiatives to Health Systems
| | | | | Hani Serag (Egypt)
GHI and Health Systems: a community perspective
| | |
|
|
|
| | T3P3 Integrated management of HIV and TB; HIV miscellaneous
Room 3 | 11.30 – 13.00 | Parallel Session | | | | | Chair: Luciano Nigro (Italy) |
| | | | Keynote Speaker:
Haileyesus Getahun (World Health Organization)
Integrated management of HIV and TB patients: So obvious, so difficult
| | | | | T3P3-01
Consequences of Treating HIV-TB – A Prospective Cohort Study
V. K. Sashindran, S. Kumar, A. Kumar and K. Namgyal | | | | | T3P3-02
Integration of TB and HIV interventions in Northern Uganda
L. Cicció, E. Tumusherure and D. Sera | | | | | T3P3-03
In silico based evaluation of efavirenz and rifampicin drug-drug interaction considering weight and pharmacogenetics
D. Rekic, D. Röshammar and M. Ashton |
| | | | T3P3-04
Tuberculosis among HIV infected children
S. Sweni, R. Meenakshisundaram, M. Vaideeswaran, M. Vasanthakumari, A. Chitra and P. Thirumalaikolundusubramanian |
| | | | T3P3-05
HIV-positive migrants face important problems of access to care in Thailand
M. Philips, A. Dahmane, A. Callewaert and T. Reid |
| | | | T3P3-06 Violence of everyday life, Prejudice, Secrecy and Adherence to Antiretroviral treatment
G. Tiendrebeogo
|
| | | | T3P3-07
Adapting prevention programs: variables that influence HIV/AIDS awareness among immigrants in Spain
L. Estévez, M. Navarro, A. Guionnet, B. Navaza, J.M. Herrero, M. Díaz, J. Pérez-Molina and R. López-Vélez
|
| |
|
|
|
| | T4P3 Chronic Degenerative Diseases
Room 4 | 11.30 – 12.20 | Parallel Session | | | | | Chair: Gianni Tognoni (Italy) |
| | | | T4P3-01
Methodology and results of a community-based prospective 5 years surveillance of a cohort of hypertensive patients in rural Ecuador
R. Prandi, M. Anselmi, M. Marquez, D. Armani, C. Caicedo, J. Murillo, S. Ibarra, J. Moreira, J. Caicedo, F. Caicedo, H. Cuero, R. Sabando, F. Peralta, C. Mero, G. Tognoni | | | | | T4P3-02
Prevalence and clinical pattern of diabetes mellitus in South-West Shewa region, Ethiopia
E. R. Bregani, A. Rovellini, M. Bettinzoli and V. Monzani |
| | | | T4P3-03
Effects of Combined Glibenclamide, Metformin and Malaysian Tualang Honey on Body Weight, Blood Glucose, Antioxidant Enzymes, Glutathione and Lipid peroxidation in Streptozotocin-Induced Diabetic Rat Pancreas
E. O. Omotayo, S. A. Sulaiman, M. S. Ab Wahab, K. N. S Sirajudeen, S. Salleh |
| | | | T4P3-04
The Ghanaian diet in the context of the epidemiological transition
I. Danquah, C. Ehrig, C. Nti, F. P. Mockenhaupt and G. Bedu-Addo
| | |
|
|
|
| | German – Sub-Saharan African collaborative research
(German Society of Tropical Medicine and International Health)
Room 5 | 11.30 – 13.00 | Workshop
| | | | | Chairs: Peter Kern (Germany), Gerd Burchard (Germany)
|
| | | | Speakers: | | | | | Rolf Horstmann (Germany)
Ten Years of Kumasi Centre of Collaborative Research in Tropical Medicine |
| | | | Peter Soboslay (Germany)
30 years of helminth disease control and field research with Togo | | | | | Michael Hoelscher (Germany)
Collaboration with MBeya Medical Research Program in Tanzania on HIV and Tuberculosis
|
| | | | Ali Sié (Burkina Faso)
The Nouna Health Research Center (CRSN) in Burkina Faso: 17 years of health research collaboration with the University Hospital Heidelberg and the future
| | | | | Benjamin Mordmueller (Germany)
Malaria vaccine development as a model for implementation of multinational networks on clinical research
|
| |
|
|
|
| | T4P4 Soil - transmitted Helminthiasis and Schistosomiasis: improving access to preventive treatment
Room 6 | 11.30 – 13.00 | Parallel Session | | | | | Chair: Alan Fenwick (United Kingdom)
|
| | | | Keynote Speakers: | | | | | Juerg Utzinger (Switzerland)
Protecting the long term efficacy of Praziquantel for Schistosomiasis control |
| | | | Antonio Montresor (World Health Organization)
Delivery of anti-helminthics through community campaigns: opportunities and challenges | | | | | T4P4-01
Reductions in environmental transmission observed with a large-scale schistosomiasis control programme in Uganda
M. French, T. Churcher, M.-G. Basénez and A. Fenwick
|
| | | | T4P4-02
Mefloquine, artesunate and mefloquine-artesunate against Schistosoma haematobium infections: a randomized exploratory open label trial
J. Keiser, N. N’Guessan, K. D. Adoubryn, C. Hatz, P. Vonatsou, J. Utzinger and E. N’Goran
|
| | | | T4P4-03
Rapid Assessment of Schistosoma Haematobium infection in Niger using school-based questionnaires
A. Phillips, A. Garba, J. Webster and A. Fenwick |
| | | | T4P4-04
Monitoring albendazole efficacy after regular treatment of soil-transmitted helminth infections in Nepali children
M. Albonico, H. Allen, P. Mathema, D. Giri, R. Shrestha and S. Pandey
| | | | | T4P4-05
Efficacy of albendazole and mebendazole alone or in combination with ivermectin against Trichuris trichiura and other soil-transmitted helminths
S. Knopp, K. A. Mohammed, B. Speich, I. S. Khamis, J. R. Stothard, D. Rollinson, H. Marti and J. Utzinger |
| |
|
|
|
| | T2P3 Malaria in pregnancy and in children
Room 7 | 11.30 – 13.00 | Parallel Session | | | | | Chair: Umberto D’Alessandro (Belgium)
|
| | | | Keynote Speakers: | | | | | Umberto D’Alessandro (Belgium)
Efficacy & safety of antimalarial treatment in pregnancy (including 1st trimester)
| | | | | François Nosten (Thailand)
ACT in the 1st trimester of pregnancy | | | | | T2P3-01
HbS and HbC traits and their effect on P. falciparum malaria phenotypes in Ghanaian infants
B. Kreuels, C. Kreuzberg, M. Ayim, B. Apiah-Thompson, R. Kobbe, C. Ehmen, S. Adjei, O. Adjei and J. May |
| | | | T2P3-02
Malaria has no effect on birth weight in Rwanda
S. Rulisa
|
| | | | T2P3-03
Malaria control in pregnancy: monitoring the effectiveness of IPTp-SP beyond the coverage with ≥2 doses
S. Gies, S. O. Coulibaly, F. T. Ouattara and U. D’Alessandro
|
| | | | T2P3-04
Intermittent Preventive Treatment during pregnancy (IPTp) by sulfadoxine pyrimetamine (SP) in a rural region of Benin: effect on placental parasitemia and low birth weight one year after national implementation of IPTp
A. Le Port, G. Cottrell, C. Dechavanne, A. Bouraima, J. Guerra, I. Choudat, A. Rachas, A. Massougbodji, F. Migot-Nabias, A. Garcia, M. Cot |
| | | | T2P3-05
Malaria treatment seeking behaviour of mothers with under 5 years old children in Binh Phouc, Vietnam
T. Abe, T. Trinh Dinh, T. Nguyen Quang, H. Le Xuan, T. Sunahara, S. Nakazawa and K. Moji |
| |
|
|
|
| | T4P5 Laboratory and Tropical Diseases
Room 4 | 12.20 – 13.00 | Parallel Session | | | | | Chairs: Marleen Boelaert (Belgium), Maria de Fátima Ferreira da Cruz (Brazil)
|
| | | | T4P5-01
Detection of Cryptosporidium with microscopy, rapid-tests, ELISA and real time PCR
M. van de Biezen-Brinkman, D. Vastert-Koop and B. Mulder | | | | | T4P5-02
Multiplex/Realtime PCR in the laboratory diagnosis and for the epidemiological screening of pathogens causing diarrhoea in early childhood in Ghana
R. M. Hagen, J. Adlkofer, S. Acqua, N. Sarpong, S. Priesnitz, Y. Adu-Sarkodie, J. Evans, F. Huenger, J. May and E. Tannich
| | | | | T4P5-03
Development of an efficient diagnostic kit for easy and fast detection of pathogenic intestinal parasitic protozoa
F. Rivero, A. Saura, C. Prucca, P. Carranza, R. Chambers, J. Crabtree and H. Lujan
|
| | | | T4P5-04
Improving the diagnostics of parasitic infections in Disease-endemic countries: making molecular diagnostics accessible
H.Schallig, G.J. Schoone, P. F. Mens, E. R. Adams, C.M. Mugasa and S. El Safi |
| |
|
|
|
| | Curing Malaria Together
(Sigma tau Medicines for Malaria Venture MMV)
Room 1 | 13.15 – 14.15 | Satellite Symposium | | | | | Chairs: Nick White (Thailand), Christopher Hentschel (Switzerland)
|
| | | | Speakers: | | | | | Marco Corsi (Italy)
From Abele Sola to Ho Chi Minh: historical references on malaria and its treatments
|
| | | | Allan Evans (Australia)
Pharmacokinetics of piperaquine and dihydroartemisinin
| | | | | Umberto D’Alessandro (Belgium)
Phase III, randomized, non-inferiority trial of dihydroartemisinin/piperaquine in comparison with artemether/lumefantrine in African children
| | | | | Neena Valcha (India)
Phase III, randomized, non-inferiority trial of dihydroartemisinin/piperaquine in comparison with artesunate/mefloquine in patients in Asia
|
| | | | Antonella Bacchieri (Italy)
Comparing the perspective of the epidemiologist with that of the regulator
|
| |
|
|
|
| | T1 The Systemic Quality Improvement (SQI) approach and the International SQI network
(GTZ – German Development Agency)
Room 5 | 13.15 – 14.15 | Workshop
| | | | | | | Chair: Klaus Peter Schnellbach (Germany) |
| | | | | | Speakers: | | | | | | | David Yondo (Congo)
What is the ”Systemic Quality Improvement” – objectives & principles, values, methods and results?
| | | | | | | Nejoua Belkaâb (Morocco), Pépé Bilivogui (Guinea), David Yondo (Congo), Rachid Sheikh Bin Shujaa (Yemen)
How does SQI work in specific countries (Guinea, Morocco, Cameroon, Congo and Yemen): results and changes obtained in health systems? Projection of the SQI film Morocco
| | | | | | | Sabine Ablefoni (GTZ), Bruno Dujardin (ULB Belgium)
The Systemic Quality Improvement Network: a new experience in coordinating and strengthening international and national expertise promoting systemic quality improvement approaches
| | | | |
|
|
|
| | MC Main Movements of people in the Mediterranean area –
Introduction to the Mediterranean Conference and Overview
Auditorium | 14.30 – 16.00 | Main Session | | | | | Chair: Francesco Castelli (Italy) | | | | | Speakers: | | | | | Louis Loutan (Switzerland)
Migrants: Leading travellers in our mobile world
|
| | | | Loris De Filippi (MSF)
Migrant health in the Mediterranean: challenges and perspectives
| | | | | Guido Sabatinelli (UNRWA, Jordan)
Health of Palestine Refugees in the Eastern Mediterranean: Determinants, Barriers and Opportunities
| | |
|
|
|
| | T1P4 Threats to access to essential medicines:
Economic crisis and counterfeited drugs
Room 1 | 14.30 – 16.00 | Parallel Session | | | | | Chair: Pierre Ambroise-Thomas (France) |
| | | | Keynote Speakers: | | | | | Hans Hogerzeil (World Health Organization)
The impact of economic crisis on the availability of essential medicines
| | | | | Yves Juillet (France)
Drug counterfeiting: raising awareness and fighting a public health threat | | | | | Paul Newton (United Kingdom)
Counterfeited antimalarials: A major problem?
|
| | | | T1P4-01
A.P.P.A.® Project: counterfeit medicines
P. Brusa, E. Rolando, I. Bellobuono, S. M. Reynaldi and A. Germano |
| |
|
|
|
| | T4P6 Leishmaniasis and Innovative Disease Management
Room 4 | 14.30 – 16.00 | Parallel Session
| | | | | Chair: Luigi Gradoni (Italy)
|
| | | | Keynote Speaker:
Shyam Sundar (India)
Improving access towards new drugs and innovative tools for leishmaniasis
| | | | | T4P6-01
Epidemiological and Entomological Survey of Visceral Leishmaniasis Focus in Tbilisi, Georgia
E. Giorgobiani, G. Babuadze, G. Chanturia, N. Chitadze, D. Sacks, P. Lawyer and S. Kamhawi | | | | | T4P6-02
The epidemiology of Leishmania donovani infection in a high transmission foci in Nepal
S. Rijal, F. Chappuis, S. Uranw, A. Picado, B. Khanal, I. Paudel, B. Ostyn, M. Das, E. Anderson, C. Davies and M. Boelaert |
| | | | T4P6-03
Incidence of asymptomatic infection with L. donovani and their evolution in high endemic villages in India and Nepal
B. Ostyn, K. Gidwani, A. Picado, F. Chappuis, B. Khanal, S. Singh, S. Rijal, S. Sundar and M. Boelaert |
| | | | T4P6-04
New recommendations for dosing of miltefosine in children with visceral leishmaniasis
T. Dorlo, A. Huitema, J. Beijnen and P. de Vries | | | | | T4P6-05
Methods for characterization and identification of miltefosine in suspected substandard capsules
T. Dorlo, P. de Vries, T. Eggelte and J. Beijnen | | | | | T4P6-06
Mass effect of village-wide use of Long Lasting Impregnated Nets on
visceral leishmaniasis vectors in India and Nepal: cluster randomized
trial
A. Picado, M. Das, V. Kumar, S. Kesari, D. Dinesh, L. Roy, S.
Rijal, P. Das, M. Rowland, M. Boelaert, M. Coosemans, C. Davies and S.
Kesari
| | |
| T4P6-07
The e-compendium: A geo-referenced bibliographical database on leishmaniasis epidemiology
J. Alvar, D. Hendrickx, J. Pickering and J.-C. Dujardin
|
|
|
|
|
|
| | Dengue Fever (DENCO & DENFRAME)
Room 5 | 14.30 – 16.00 | Workshop
| | | | | Chairs: Natalie Pardignon (France) and Thomas Janisch (Germany)
|
| | | | Speakers: |
| | | | Bridget Wills (United Kingdom)
Mechanisms of vascular leakage and bleeding during dengue infections | | | | | Natalie Pardignon (France)
The DENFRAME project: A productive international program dedicated to a comprehensive study of dengue disease | | | | | Patrick Van der Stuyft (Belgium)
Effectiveness of insecticide treated materials for Aedes aegypti control in Venezuela | | | | | Thomas Janisch (Germany)
Evidence for a revised dengue case classification: results from a multi-centre prospective study across Southeast Asia and Latin America |
| | | | Maria Guadalupe Guzman (Cuba)
Multi-country evaluation of the sensitivity and specificity of two commerciallyavailable NS1 ELISA assays for dengue diagnosis
|
| |
|
|
|
| | Writing a paper
Room 6 | 14.30 – 17.30 | Course
| | | | | Chair and lecturer:
Susanne Groener (Managing Editor, Tropical Medicine and International Health)
|
| | | | A nuts-and-bolts overview of the mechanics of writing biomedical research papers, addressing basics such as word choice, syntax and paragraph structure as well as the contents and structure of each section (IMRD) and supplementary information (references, abstracts) | | |
|
|
|
| | T2P4 Expanding access to ACTs
Room 7 | 14.30 – 16.00 | Parallel Session | | | | | Keynote Speaker:
Ambrose Talisuna (Uganda)
Ensuring global access to ACTs and targeting their use |
| | | | T2P4-01
Successful introduction of artesunate and amodiaquine is not enough to fight malaria - results from an adherence study in Sierra Leone
S. Gerstl, S. Dunkley, A. Mukhtar, S. Baker and J. Maikere | | | | | T2P4-02
Increased access to malaria diagnosis and treatment through free care provided in health centres and by malaria village workers in Chad, Mali and Sierra Leone
M. De Smet, M. Philips, F. Ponsar, S. Gerard and M. Van Herp
|
| | | | T2P4-03
Understanding and improving access to prompt and effective malaria treatment: the ACCESS project in Tanzania
F. Kessy, M. Hetzel, S. Alba, I. Mayumana, A. Dillip, C. Lengeler, B. Obrist, A. Schulze and H. Mshinda |
| | | | T2P4-04
Exposure to lumefantrine in infants and children receiving artemetherlumefantrine for acute uncomplicated malaria: impact of African diet
components
U. D’Alessandro, A. Nahum, E. Juma, W. M. Sallas, J. Lyimo, A.-C. Marrast, G. Lefevre and A. Djimde |
| | | | T2P4-05
Access to malaria treatment in rural Tanzania after switch to ACT
S. Alba, A. Dillip, I. Mayumana, C. Lengeler, M. Alexander, R. Nathan, A. Schulze, B. Obrist, F. Kessy and H. Mshinda
| | | | | T2P4-06
Functioning Public Health Service System in Early Diagnosis and Treatment of Malaria in the National Malaria Control Programme – Vietnam
H. Le Xuan | | | | | T2P4-07
Pharmacovigilance of artemether-lumefantrine in pregnant women followed up till delivery in Rwanda
S. Rulisa | | |
|
|
|
| | MCP1 Access to care and to prevention in migrants
Auditorium | 16.30 – 17.30 | Parallel Session
| | | | | Keynote Speaker:
Ron Behrens (United Kingdom)
Going back home (VFR): Cost-effectiveness of preventive measures |
| | | | MCP1-01
Approaching Beliefs and Risk Perception in Immigrants Travelers Visiting Friends and Relatives (VFRs) in order to Adapt a Preventive Program
B. Navaza, A. Guionnet, M. Navarro, L. Estevez, B. Monge, F. Norman, J. Perez-Molina and R. Lopez-Velez |
| | | | MCP1-02
Improving health care for immigrant pediatric patients and families with sickle cell disease (SCD) through the design and production of a three language, image-rich educational book: "Sickle Cell Disease: information and advice for children and parents"
R. Colombatti, M. Pierobon and L. Sainati | | | | | MCP1-03 Unhealthy conditions and lack of care in detention centres for migrants, Malta
L. Schockaert and G. De Molla
|
| | | | MCP1-04
Ethical and public health concerns based on the retrospective analysis of referrals for diagnostic parasitology of immigrants and autochthonous population in Lampedusa island (Italy)
L. Bellina, M. Maugeri and E. Missoni |
| |
|
|
|
| | MCP2 Research needs in migrants’ health
Room 1 | 16.30 – 17.30 | Parallel Session
| | | | | Chair: Issah el Hamad (Italy)
|
| | | | Keynote Speaker:
Sanaa Kamal (Egypt)
Hepatitis C virus genotype 4: What we know and we don’t know yet
| | | | | MCP2-01
Differences in the frequency of primary care medical visits between immigrants and Spanish nationals
L. A. Gimeno Feliu, M. Lasheras, A. Eva, I. Dolsac, L. Luzon and M. Magallon-Botaya |
| | | | MCP2-02
A social health model supporting undocumented immigrants in Italy
T. Iacovazzi, R. Ravinetto, L. De Filippi, M. Sarboraria, A. Oriti, F. Faraglia, C. Lodesani and K. Moschochoritis |
| | | | MCP2-03
Intercultural Mediation as a solution to linguistic and cultural conflicts between health personnel and migrant patients and a way to social integration
A. Guionnet, L. Estevez, B. Navaza, M. Navarro, L. C. Martinez and R. Lopez-Velez |
| |
|
|
|
| | T3P4 Gender disparities in TB and HIV:
Evidences and strategies
Room 3 | 16.30 – 17.30 | Parallel Session
| | | | | Chair: Anna Cavalli (Italy)
| | | | | T3P4-01
Epidemiology of the HIV/AIDS epidemic: The reasons for the increasing number of women infected with HIV in Eastern Europe
L. Burruano | | | | | T3P4-02
HIV/AIDS and Response of Troubled Youth
M. U. Farooq | | | | | T3P4-03
HIV and Sexual practices of Transgender community in Pakistan
M. U. Farooq | | | | | T3P4-04
Awareness of HIV sero-status among pregnant women in Northern Uganda: a cross-sectional assessment
L. Ciccio, D. Sera | | | | | T3P4-05
Vitamin D Status of HIV-infected Women and its Relationship with HIV Disease Progression, Anemia, and Mortality
S. Mehta, E. Giovannucci, F. Mugusi, D. Spiegelman, S. Aboud, E. Hertzmark, G. Msamanga, D. Hunter and W. Fawzi | | |
|
|
|
| | T4P7 Diseases targeted to Elimination 1: Leprosy
Room 4 | 16.30 – 17.30 | Parallel Session
| | | | | Chair: Lorenzo Savioli (World Health Organization)
|
| | | | Keynote Speaker:
Salvatore Noto (Italy)
Leprosy: Will it soon be eradicated? | | | | | T4P7-01
Disability in people affected with leprosy: stigma, social participation and discrimination
B. Sihombing, A. Wilder-Smith, D. Hernani, R. Yulihane, M. Kasim, K. Beise and W. van Brakel |
| | | | T4P7-02
Hansen’s disease endemic control in the Amazon
A. Lopez-Gonzalez
| | |
|
|
|
| | T2 Malaria eradication : A realistic target?
Pro’s and con’s, how and when (Swiss Society of Tropical Medicine)
Room 7 | 16.30 – 18.30 | Round Table
| | | | | Moderator:
Christian Lengeler (Switzerland) | | | | | Discussants:
Richard Feachem (United States),
Awa Coll-Seck (World Health Organization),
Ambrose Talisuna (Uganda),
Fred Binka (Ghana) | | |
|
|
|
| | MCP3 Selected Pre-Travel Topics
Auditorium | 17.30 – 18.30 | Parallel Session
| | | | | Chair: Vincenzo Nicosia (Italy) |
| | | | Keynote Speakers:
|
| | | | Pat Schlagenhauf (Switzerland)
Malaria prevention and management for long term travellers | | | | | Claire-Lise Chaignat (World Health Organization)
The new oral cholera vaccine: a solution for all? |
| | | | Gilles Poumerol
Recent developments in Yellow Fever risk mapping | | |
|
|
|
| | MCP4 Miscellaneous on Migrant Health
Room 1 | 17.30 – 18.30 | Parallel Session | | | | | Chair: Philippe Parola (France) |
| | | | MCP4-01
Sickle Cell Disease affected children: an increasing group of children born in Europe from immigrant families. A single Center experience in Italy
R. Colombatti, C. Marin, A. Rossetto, C. Bodon and L. Sainati |
| | | | MCP4-02
Undocumented female immigrants in the Netherlands have unmet needs in sexual and reproductive health
M. Schoevers, M. van den Muijsenbergh and A. Lagro-Janssen |
| | | | MCP4-03
In the relationship between physician and foreign patient the linguistic misunderstanding is a lexical problem or a semantic problem?
E. De Blasio and R. Colasanti | | | | | MCP4-04
Comparative study of paediatric prescription drug utilization between the Spanish and immigrant population
L. A. Gimeno Feliu, F. J. Armesto, R. M. Macipe Costa, E. Andres Esteban and R. Magallon Botaya |
| | | | MCP4-05
The experience of surgery "Salute senza Margini" dedicated to immigrants without residence permit in the Health District of Casalecchio di Reno of Azienda Unita Sanitaria Locale (AUSL) of Bologna
S. Moscardelli, S. M. Di Ciommo, S. Aristei, C. Veronesi, A. Larocca, S. Mellini, A. Guerrieri, U. Zannoni, G. Pascali, M. Monti and R. Nicoletti |
| | | | MCP4-06
Knowledge, attitudes and practices (KAP) study regarding to malaria transmission and protection among Afghan refugees and comparing with Iranian resident Southeastern Iran
H. Basseri, A. Raeisi, K. Holakouie, K. Shahandeh |
| |
|
|
|
| | T1 Ethical criteria in clinical research in developing countries: Is there a global standard?
Room 3 | 17.30 – 18.30 | Debate |
| | | | Moderator:
Raffaella Ravinetto (Belgium)
| | | | | Discussants:
Lumuli Mbonile (Tanzania), Nick White (Thailand)
| | |
|
|
|
| | T4P8 Diseases targeted to elimination 2: Filariasis, Taeniasis
Room 4 | 17.30 – 18.30 | Parallel Session | | | | | Chair: David Molyneux (United Kingdom) |
| | | | Keynote Speakers: |
| | | | Silvio Paolo Mariotti (World Health Organization)
Neglected blindness and new tools for control in public health | | | | | Hector Hugo Garcia (Peru)
Elimination of Zoonotic Larval Cestode Infections (cysticercosis, echinococcosis): Is it within reach?
| | | | | T4P8-01
Factors influencing the microfilarial load of Onchocerca volvulus six months after a first dose of ivermectin
L. Grout, S. Pion, H. Nana-Djeunga, J. Kamgno, S. Wanji and M. Boussinesq | | | | | T4P8-02
The Taenia solium Genome Project: Progress Report
A. Garciarrubio, K. Estrada, R. J. Bobes, J. C. Carrero, M. A. Cevallos, J. L. Fernandez, G. Fragoso, P. Gaytan, V. M. Gonzalez, M. J. Valenzuela, L. Jimenez, M. S. Juarez, A. Landa, C. Larralde, J. Limon Lasson, L. Mendoza, J. Morales Montor, E. Morett, A. Sanchez, E. Sciutto, X. Soberon, P. de la Torre, V. Valdes, J. Yanez and J. P. Laclette | | |
|
|
|
| | T5P2 Access to reproductive health services
Room 5 | 17.30 – 18.30 | Parallel Session | | | | | Chair and Keynote Speaker: Vincent De Brouwere (Belgium)
Successful and less successful examples on improving access to safe delivery and care of the newborn | | | | | T5P2-01
Effects of women’s bargaining power on institutional delivery and unmet needs for family planning in Burkina Faso
B. Nikiema
|
| | | | T5P2-02
The Pregnant Woman and Her Cultural Context. The dialectic of access at southern Mozambique
M. C. Alvarez Degregori and A. Parruque David |
| | | | T5P2-03
Aama Programme: A Demand Side Financing to Reduce Maternal and Newborn Deaths in Nepal
S. Tiwari and B. K. Suvedi | | | | | T5P2-04
Access to Emergency Obstetric Care in rural Zambia – Linking national data in a Geographic Information System
S. Gabrysch, S. Cousens, J. Cox and O. Campbell |
| |
|
|
|
| | T4P9 Chagas Disease
Room 6 | 17.30 – 18.30 | Parallel Session | | | | | Chairs: Faustino Torrico (Bolivia), Elias Canas (Spain)
|
| | | | T4P9-01
Imported Chagas disease in Italy: preliminary screening results of selected immigrant populations
M. Anselmi, A. Angheben, M. Degani, S. Tais, I. Spreafico, E. Bonifacio, F. Gobbi, M. Talamo, M.M. Ferrari, F. Suter, G. Zavarise, Z. Bisoffi
| | | | | T4P9-02
Chagas disease in Spain: results of a Public Health Program tailored to Migrants from Latin-America
M. Navarro, A. Guionnet, A. Perez de Ayala, Y. Quintero, L. Estevez, B. Navaza, J. Perez-Molina and R. Lopez-Velez | | | | | T4P9-03
Intracelullar cytokines in Chagas' disease and HIV infection
T. R. Tozetto Mendoza, D. de Moraes Vasconcelos, K. Yaqub Ibraim, A. M. Cristovan Sartori and M. A. Shikanai Yasuda |
| | | | T4P9-04
Age-group analysis of benznidazole treatment-related adverse events in children and adolescents in three Chagas disease programs in Bolivia, 2002-2009
W. Chambi, T. Ellman, S. Castillo, O. Yun, M. A. Lima and P. P. Palma | | | | | T4P9-05
Poor tolerance of nifurtimox among Latin American adult immigrants with chronic Chagas disease
Y. Jackson, L. Getaz, A. Tardin, T. Collipal – Von Wyl, E. Alirol and F. Chappuis |
| | | | T4P9-06
Age-group analysis of Trypanosoma cruzi seroprevalence in children and adolescents in three Chagas disease diagnosis and treatment programs in Bolivia, 2002 – 2009
T. Ellman, W. Chambi, L. Vargas Loza, S. Castillo, O. Yun, M. Rojas Cortez, M. A. Lima and P. P. Palma | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
